Retailer的个人主页 - 老虎社区

Retailer

Retailer

暂无个人介绍

IP属地：未知

23关注

2粉丝

0主题

0勋章

2021-10-03

Thanks , added Veeva in my watchlist

2 Leading Healthcare Stocks to Buy in 2021 and Beyond

2021-09-01

Good news.

Meaningful recovery for hospitality sector likely in 2022: OCBC

2021-10-20

Thank you for sharinf

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586754499068036","uuid":"3586754499068036","gmtCreate":1623667430635,"gmtModify":1626415823372,"name":"Retailer","pinyin":"retailer","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":23,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":859695039,"gmtCreate":1634690870572,"gmtModify":1634690870688,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Thank you for sharinf","listText":"Thank you for sharinf","text":"Thank you for sharinf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859695039","repostId":"2175144894","repostType":2,"isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867838856,"gmtCreate":1633235014714,"gmtModify":1633235014714,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Thanks , added Veeva in my watchlist","listText":"Thanks , added Veeva in my watchlist","text":"Thanks , added Veeva in my watchlist","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867838856","repostId":"2172964534","repostType":4,"repost":{"id":"2172964534","kind":"highlight","pubTimestamp":1633221732,"share":"https://www.laohu8.com/m/news/2172964534?lang=&edition=full","pubTime":"2021-10-03 08:42","market":"us","language":"en","title":"2 Leading Healthcare Stocks to Buy in 2021 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2172964534","media":"Motley Fool","summary":"The future looks bright with these two supercharged stocks.","content":"<p>If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, <a href=\"https://laohu8.com/S/AONE.U\">one</a> excellent industry to look at is healthcare. While not all stocks in this sector perform the same in turbulent markets, many do provide products and services that customers need regardless of the economy -- and this can lend resilience to a long-term investor's portfolio.</p>\n<p>To that end, today, we're going to take a look at two high-growth companies in the healthcare space. One is a leader in medical robotics while the other helps healthcare companies run their businesses more efficiently. Let's get started.</p>\n<p><img src=\"https://static.tigerbbs.com/bc209e3e1fc5ad6f0407e698d4c85f5c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. Intuitive Surgical</h2>\n<p>Medical robotics pioneer<b> Intuitive Surgical</b> (NASDAQ:ISRG) was founded in 1995 and has been a publicly traded entity for more than two decades. Since the IPO, its shares have skyrocketed more than 16,000%. In the past year alone, the stock is up more than 40%. With its shares now trading just shy of $1,000, it's no surprise that the company is planning to undergo a stock split in early October.</p>\n<p>The stock has soared for good reason. Intuitive dominates the global surgical robotics market (more than three-quarters of it, in fact), most notably with its da Vinci Surgical System. Its approach has become more and more widely accepted -- and so Intuitive's revenue over the past decade has grown nearly 150% while net income has risen about 114%.</p>\n<p>And the company is just getting started. The global surgical robotics industry is expected to grow exponentially in the years ahead as an increasing number of medical providers utilize these tools in minimally invasive procedures due to their efficiency, accuracy, and ability to generate more positive post-surgery outcomes, such as shorter inpatient care.</p>\n<p>An investment in Intuitive Surgical could generate sustained returns for many years as it expands its footprint in this multi-billion-dollar industry and as reliance on surgical robotics continues to grow.</p>\n<h2>2. Veeva Systems</h2>\n<p>Cloud solutions provider <b>Veeva Systems</b> (NYSE:VEEV) may not be a name that immediately comes to mind when thinking about the healthcare sector, but it's a compelling choice for long-term investors to consider. The company helps healthcare companies -- ranging from household-name pharmaceutical giants to smaller life sciences entities -- effectively store their information.</p>\n<p>Veeva clients seem to appreciate what they do. The company has a long and respectable history of growth, having increased revenue more than 160% and net income nearly 390% over the past five years.</p>\n<p>And the company remains on track. For the first half of its fiscal 2022 (ended Jul. 31), Veeva reported a revenue increase of about 29% from the year-ago period. This was driven by a 28% boost in its subscription services as well as a 33% increase in its professional and other services. Net income increased about 25% during the same time period.</p>\n<p>Veeva's stock isn't cheap, trading at around $285 a share and a price-to-sales (P/S) ratio of about 26. But it's also safe to say that these kinds of valuations are something investors have come to expect from stocks in the high-growth SaaS space. Shares of the company have consistently appreciated over the years -- and even at its current premium valuation, Wall Street thinks the stock has upside of as much as 40% over the next 12 months.</p>\n<p>Finally, demand for Veeva's products and services isn't likely going anywhere, and its list of customers -- including such big names as <b>Merck</b>, <b>Eli Lilly</b>, and <b>Bayer </b>-- is only growing. Veeva Systems is a stock for the long haul. And if you're not thrilled about its current price, there's no harm in dipping your toe by investing in fractional shares of this stock for now.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Leading Healthcare Stocks to Buy in 2021 and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Leading Healthcare Stocks to Buy in 2021 and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 08:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, one excellent industry to look at is healthcare. While...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172964534","content_text":"If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, one excellent industry to look at is healthcare. While not all stocks in this sector perform the same in turbulent markets, many do provide products and services that customers need regardless of the economy -- and this can lend resilience to a long-term investor's portfolio.\nTo that end, today, we're going to take a look at two high-growth companies in the healthcare space. One is a leader in medical robotics while the other helps healthcare companies run their businesses more efficiently. Let's get started.\n\nImage source: Getty Images.\n1. Intuitive Surgical\nMedical robotics pioneer Intuitive Surgical (NASDAQ:ISRG) was founded in 1995 and has been a publicly traded entity for more than two decades. Since the IPO, its shares have skyrocketed more than 16,000%. In the past year alone, the stock is up more than 40%. With its shares now trading just shy of $1,000, it's no surprise that the company is planning to undergo a stock split in early October.\nThe stock has soared for good reason. Intuitive dominates the global surgical robotics market (more than three-quarters of it, in fact), most notably with its da Vinci Surgical System. Its approach has become more and more widely accepted -- and so Intuitive's revenue over the past decade has grown nearly 150% while net income has risen about 114%.\nAnd the company is just getting started. The global surgical robotics industry is expected to grow exponentially in the years ahead as an increasing number of medical providers utilize these tools in minimally invasive procedures due to their efficiency, accuracy, and ability to generate more positive post-surgery outcomes, such as shorter inpatient care.\nAn investment in Intuitive Surgical could generate sustained returns for many years as it expands its footprint in this multi-billion-dollar industry and as reliance on surgical robotics continues to grow.\n2. Veeva Systems\nCloud solutions provider Veeva Systems (NYSE:VEEV) may not be a name that immediately comes to mind when thinking about the healthcare sector, but it's a compelling choice for long-term investors to consider. The company helps healthcare companies -- ranging from household-name pharmaceutical giants to smaller life sciences entities -- effectively store their information.\nVeeva clients seem to appreciate what they do. The company has a long and respectable history of growth, having increased revenue more than 160% and net income nearly 390% over the past five years.\nAnd the company remains on track. For the first half of its fiscal 2022 (ended Jul. 31), Veeva reported a revenue increase of about 29% from the year-ago period. This was driven by a 28% boost in its subscription services as well as a 33% increase in its professional and other services. Net income increased about 25% during the same time period.\nVeeva's stock isn't cheap, trading at around $285 a share and a price-to-sales (P/S) ratio of about 26. But it's also safe to say that these kinds of valuations are something investors have come to expect from stocks in the high-growth SaaS space. Shares of the company have consistently appreciated over the years -- and even at its current premium valuation, Wall Street thinks the stock has upside of as much as 40% over the next 12 months.\nFinally, demand for Veeva's products and services isn't likely going anywhere, and its list of customers -- including such big names as Merck, Eli Lilly, and Bayer -- is only growing. Veeva Systems is a stock for the long haul. And if you're not thrilled about its current price, there's no harm in dipping your toe by investing in fractional shares of this stock for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":816134012,"gmtCreate":1630476460336,"gmtModify":1633677778050,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Good news.","listText":"Good news.","text":"Good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/816134012","repostId":"1170712764","repostType":4,"repost":{"id":"1170712764","kind":"news","pubTimestamp":1630463152,"share":"https://www.laohu8.com/m/news/1170712764?lang=&edition=full","pubTime":"2021-09-01 10:25","market":"sg","language":"en","title":"Meaningful recovery for hospitality sector likely in 2022: OCBC","url":"https://stock-news.laohu8.com/highlight/detail?id=1170712764","media":"Singapore Business","summary":"OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a ","content":"<blockquote>\n <i><b>OCBC Investment Research expects hospitality REITs to post stronger second-half results.</b></i>\n</blockquote>\n<p>Despite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment Research expects stronger overall results from the hospitality sector in the second half (H2).</p>\n<p>Moreover, OCBC said meaningful recovery would finally be apparent next year.</p>\n<p>“With increasing vaccination rates and further easing of restrictions, we could see a better H2 2021 and expect the recovery momentum to continue into 2H21, although a more meaningful recovery would likely happen in 2022, following the resumption of travel confidence,” OCBC Investment Research said in a report.</p>\n<p>OCBC looked into the results of three REITs in their report: Ascott Residence Trust (ART), CDL Hospitality Trusts (CDLHT), and Far East Hospitality Trust (FEHT). Whilst Ascott posted a 95% distribution per unit growth in the first half, Far East and CDL lagged behind with a 7% growth and 19% contraction, respectively.</p>\n<p>It noted that demand for hotels was still primarily supported by the government, as hotels serving as isolation facilities jumped to more than 90 as of 4 August from over 70 in May.</p>\n<p>“Currently, six out of FEHT’s nine hotels, two out of ART’s three Singapore properties, and five out of CDLHT’s six Singapore hotels are on government isolation businesses. REIT Managers see a high likelihood that existing contracts would be extended in [the third quarter of 2021] as the COVID-19 situation remains fluid, and governments may still need some inventory of rooms for imported cases. These could continue to provide income support before an eventual recovery of the hospitality sector as Singapore progressively reopens its borders,” OCBC said.</p>\n<p>It flagged as a potential downside risk of more COVID-19 infections due to the Delta variant.</p>\n<p>Potential growth drivers include high vaccination rates, the vaccinated travel lanes with Germany and Brunei starting 8 September, and the lifting of border restrictions for visitors from Hong Kong and Brunei.</p>\n<p>“As governments step up immunisation efforts both locally and globally, Singapore is likely to reopen its borders to more destinations in a careful and calibrated manner. Whilst visitor arrivals may remain muted in the near term as vaccination rates and border measures vary in countries, we believe the reopening of borders marks a measured start to the resumption of air travel, aiding the recovery of the hospitality sector, barring the risks of a potential spike in Delta variant cases,” OCBC said.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meaningful recovery for hospitality sector likely in 2022: OCBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeaningful recovery for hospitality sector likely in 2022: OCBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-01 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment ...</p>\n\n<a href=\"https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170712764","content_text":"OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment Research expects stronger overall results from the hospitality sector in the second half (H2).\nMoreover, OCBC said meaningful recovery would finally be apparent next year.\n“With increasing vaccination rates and further easing of restrictions, we could see a better H2 2021 and expect the recovery momentum to continue into 2H21, although a more meaningful recovery would likely happen in 2022, following the resumption of travel confidence,” OCBC Investment Research said in a report.\nOCBC looked into the results of three REITs in their report: Ascott Residence Trust (ART), CDL Hospitality Trusts (CDLHT), and Far East Hospitality Trust (FEHT). Whilst Ascott posted a 95% distribution per unit growth in the first half, Far East and CDL lagged behind with a 7% growth and 19% contraction, respectively.\nIt noted that demand for hotels was still primarily supported by the government, as hotels serving as isolation facilities jumped to more than 90 as of 4 August from over 70 in May.\n“Currently, six out of FEHT’s nine hotels, two out of ART’s three Singapore properties, and five out of CDLHT’s six Singapore hotels are on government isolation businesses. REIT Managers see a high likelihood that existing contracts would be extended in [the third quarter of 2021] as the COVID-19 situation remains fluid, and governments may still need some inventory of rooms for imported cases. These could continue to provide income support before an eventual recovery of the hospitality sector as Singapore progressively reopens its borders,” OCBC said.\nIt flagged as a potential downside risk of more COVID-19 infections due to the Delta variant.\nPotential growth drivers include high vaccination rates, the vaccinated travel lanes with Germany and Brunei starting 8 September, and the lifting of border restrictions for visitors from Hong Kong and Brunei.\n“As governments step up immunisation efforts both locally and globally, Singapore is likely to reopen its borders to more destinations in a careful and calibrated manner. Whilst visitor arrivals may remain muted in the near term as vaccination rates and border measures vary in countries, we believe the reopening of borders marks a measured start to the resumption of air travel, aiding the recovery of the hospitality sector, barring the risks of a potential spike in Delta variant cases,” OCBC said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":867838856,"gmtCreate":1633235014714,"gmtModify":1633235014714,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Thanks , added Veeva in my watchlist","listText":"Thanks , added Veeva in my watchlist","text":"Thanks , added Veeva in my watchlist","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867838856","repostId":"2172964534","repostType":4,"repost":{"id":"2172964534","kind":"highlight","pubTimestamp":1633221732,"share":"https://www.laohu8.com/m/news/2172964534?lang=&edition=full","pubTime":"2021-10-03 08:42","market":"us","language":"en","title":"2 Leading Healthcare Stocks to Buy in 2021 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2172964534","media":"Motley Fool","summary":"The future looks bright with these two supercharged stocks.","content":"<p>If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, <a href=\"https://laohu8.com/S/AONE.U\">one</a> excellent industry to look at is healthcare. While not all stocks in this sector perform the same in turbulent markets, many do provide products and services that customers need regardless of the economy -- and this can lend resilience to a long-term investor's portfolio.</p>\n<p>To that end, today, we're going to take a look at two high-growth companies in the healthcare space. One is a leader in medical robotics while the other helps healthcare companies run their businesses more efficiently. Let's get started.</p>\n<p><img src=\"https://static.tigerbbs.com/bc209e3e1fc5ad6f0407e698d4c85f5c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. Intuitive Surgical</h2>\n<p>Medical robotics pioneer<b> Intuitive Surgical</b> (NASDAQ:ISRG) was founded in 1995 and has been a publicly traded entity for more than two decades. Since the IPO, its shares have skyrocketed more than 16,000%. In the past year alone, the stock is up more than 40%. With its shares now trading just shy of $1,000, it's no surprise that the company is planning to undergo a stock split in early October.</p>\n<p>The stock has soared for good reason. Intuitive dominates the global surgical robotics market (more than three-quarters of it, in fact), most notably with its da Vinci Surgical System. Its approach has become more and more widely accepted -- and so Intuitive's revenue over the past decade has grown nearly 150% while net income has risen about 114%.</p>\n<p>And the company is just getting started. The global surgical robotics industry is expected to grow exponentially in the years ahead as an increasing number of medical providers utilize these tools in minimally invasive procedures due to their efficiency, accuracy, and ability to generate more positive post-surgery outcomes, such as shorter inpatient care.</p>\n<p>An investment in Intuitive Surgical could generate sustained returns for many years as it expands its footprint in this multi-billion-dollar industry and as reliance on surgical robotics continues to grow.</p>\n<h2>2. Veeva Systems</h2>\n<p>Cloud solutions provider <b>Veeva Systems</b> (NYSE:VEEV) may not be a name that immediately comes to mind when thinking about the healthcare sector, but it's a compelling choice for long-term investors to consider. The company helps healthcare companies -- ranging from household-name pharmaceutical giants to smaller life sciences entities -- effectively store their information.</p>\n<p>Veeva clients seem to appreciate what they do. The company has a long and respectable history of growth, having increased revenue more than 160% and net income nearly 390% over the past five years.</p>\n<p>And the company remains on track. For the first half of its fiscal 2022 (ended Jul. 31), Veeva reported a revenue increase of about 29% from the year-ago period. This was driven by a 28% boost in its subscription services as well as a 33% increase in its professional and other services. Net income increased about 25% during the same time period.</p>\n<p>Veeva's stock isn't cheap, trading at around $285 a share and a price-to-sales (P/S) ratio of about 26. But it's also safe to say that these kinds of valuations are something investors have come to expect from stocks in the high-growth SaaS space. Shares of the company have consistently appreciated over the years -- and even at its current premium valuation, Wall Street thinks the stock has upside of as much as 40% over the next 12 months.</p>\n<p>Finally, demand for Veeva's products and services isn't likely going anywhere, and its list of customers -- including such big names as <b>Merck</b>, <b>Eli Lilly</b>, and <b>Bayer </b>-- is only growing. Veeva Systems is a stock for the long haul. And if you're not thrilled about its current price, there's no harm in dipping your toe by investing in fractional shares of this stock for now.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Leading Healthcare Stocks to Buy in 2021 and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Leading Healthcare Stocks to Buy in 2021 and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 08:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, one excellent industry to look at is healthcare. While...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/02/2-leading-healthcare-stocks-buy-in-2021-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172964534","content_text":"If you're looking for new stocks to add to your portfolio that can generate sustained growth and keep generating returns in all kinds of markets, one excellent industry to look at is healthcare. While not all stocks in this sector perform the same in turbulent markets, many do provide products and services that customers need regardless of the economy -- and this can lend resilience to a long-term investor's portfolio.\nTo that end, today, we're going to take a look at two high-growth companies in the healthcare space. One is a leader in medical robotics while the other helps healthcare companies run their businesses more efficiently. Let's get started.\n\nImage source: Getty Images.\n1. Intuitive Surgical\nMedical robotics pioneer Intuitive Surgical (NASDAQ:ISRG) was founded in 1995 and has been a publicly traded entity for more than two decades. Since the IPO, its shares have skyrocketed more than 16,000%. In the past year alone, the stock is up more than 40%. With its shares now trading just shy of $1,000, it's no surprise that the company is planning to undergo a stock split in early October.\nThe stock has soared for good reason. Intuitive dominates the global surgical robotics market (more than three-quarters of it, in fact), most notably with its da Vinci Surgical System. Its approach has become more and more widely accepted -- and so Intuitive's revenue over the past decade has grown nearly 150% while net income has risen about 114%.\nAnd the company is just getting started. The global surgical robotics industry is expected to grow exponentially in the years ahead as an increasing number of medical providers utilize these tools in minimally invasive procedures due to their efficiency, accuracy, and ability to generate more positive post-surgery outcomes, such as shorter inpatient care.\nAn investment in Intuitive Surgical could generate sustained returns for many years as it expands its footprint in this multi-billion-dollar industry and as reliance on surgical robotics continues to grow.\n2. Veeva Systems\nCloud solutions provider Veeva Systems (NYSE:VEEV) may not be a name that immediately comes to mind when thinking about the healthcare sector, but it's a compelling choice for long-term investors to consider. The company helps healthcare companies -- ranging from household-name pharmaceutical giants to smaller life sciences entities -- effectively store their information.\nVeeva clients seem to appreciate what they do. The company has a long and respectable history of growth, having increased revenue more than 160% and net income nearly 390% over the past five years.\nAnd the company remains on track. For the first half of its fiscal 2022 (ended Jul. 31), Veeva reported a revenue increase of about 29% from the year-ago period. This was driven by a 28% boost in its subscription services as well as a 33% increase in its professional and other services. Net income increased about 25% during the same time period.\nVeeva's stock isn't cheap, trading at around $285 a share and a price-to-sales (P/S) ratio of about 26. But it's also safe to say that these kinds of valuations are something investors have come to expect from stocks in the high-growth SaaS space. Shares of the company have consistently appreciated over the years -- and even at its current premium valuation, Wall Street thinks the stock has upside of as much as 40% over the next 12 months.\nFinally, demand for Veeva's products and services isn't likely going anywhere, and its list of customers -- including such big names as Merck, Eli Lilly, and Bayer -- is only growing. Veeva Systems is a stock for the long haul. And if you're not thrilled about its current price, there's no harm in dipping your toe by investing in fractional shares of this stock for now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":816134012,"gmtCreate":1630476460336,"gmtModify":1633677778050,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Good news.","listText":"Good news.","text":"Good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/816134012","repostId":"1170712764","repostType":4,"repost":{"id":"1170712764","kind":"news","pubTimestamp":1630463152,"share":"https://www.laohu8.com/m/news/1170712764?lang=&edition=full","pubTime":"2021-09-01 10:25","market":"sg","language":"en","title":"Meaningful recovery for hospitality sector likely in 2022: OCBC","url":"https://stock-news.laohu8.com/highlight/detail?id=1170712764","media":"Singapore Business","summary":"OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a ","content":"<blockquote>\n <i><b>OCBC Investment Research expects hospitality REITs to post stronger second-half results.</b></i>\n</blockquote>\n<p>Despite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment Research expects stronger overall results from the hospitality sector in the second half (H2).</p>\n<p>Moreover, OCBC said meaningful recovery would finally be apparent next year.</p>\n<p>“With increasing vaccination rates and further easing of restrictions, we could see a better H2 2021 and expect the recovery momentum to continue into 2H21, although a more meaningful recovery would likely happen in 2022, following the resumption of travel confidence,” OCBC Investment Research said in a report.</p>\n<p>OCBC looked into the results of three REITs in their report: Ascott Residence Trust (ART), CDL Hospitality Trusts (CDLHT), and Far East Hospitality Trust (FEHT). Whilst Ascott posted a 95% distribution per unit growth in the first half, Far East and CDL lagged behind with a 7% growth and 19% contraction, respectively.</p>\n<p>It noted that demand for hotels was still primarily supported by the government, as hotels serving as isolation facilities jumped to more than 90 as of 4 August from over 70 in May.</p>\n<p>“Currently, six out of FEHT’s nine hotels, two out of ART’s three Singapore properties, and five out of CDLHT’s six Singapore hotels are on government isolation businesses. REIT Managers see a high likelihood that existing contracts would be extended in [the third quarter of 2021] as the COVID-19 situation remains fluid, and governments may still need some inventory of rooms for imported cases. These could continue to provide income support before an eventual recovery of the hospitality sector as Singapore progressively reopens its borders,” OCBC said.</p>\n<p>It flagged as a potential downside risk of more COVID-19 infections due to the Delta variant.</p>\n<p>Potential growth drivers include high vaccination rates, the vaccinated travel lanes with Germany and Brunei starting 8 September, and the lifting of border restrictions for visitors from Hong Kong and Brunei.</p>\n<p>“As governments step up immunisation efforts both locally and globally, Singapore is likely to reopen its borders to more destinations in a careful and calibrated manner. Whilst visitor arrivals may remain muted in the near term as vaccination rates and border measures vary in countries, we believe the reopening of borders marks a measured start to the resumption of air travel, aiding the recovery of the hospitality sector, barring the risks of a potential spike in Delta variant cases,” OCBC said.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meaningful recovery for hospitality sector likely in 2022: OCBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeaningful recovery for hospitality sector likely in 2022: OCBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-01 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment ...</p>\n\n<a href=\"https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://sbr.com.sg/hotels-tourism/in-focus/meaningful-recovery-hospitality-sector-likely-in-2022-ocbc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170712764","content_text":"OCBC Investment Research expects hospitality REITs to post stronger second-half results.\n\nDespite a mixed back of results from top hospitality REITs in the first half of the year, OCBC Investment Research expects stronger overall results from the hospitality sector in the second half (H2).\nMoreover, OCBC said meaningful recovery would finally be apparent next year.\n“With increasing vaccination rates and further easing of restrictions, we could see a better H2 2021 and expect the recovery momentum to continue into 2H21, although a more meaningful recovery would likely happen in 2022, following the resumption of travel confidence,” OCBC Investment Research said in a report.\nOCBC looked into the results of three REITs in their report: Ascott Residence Trust (ART), CDL Hospitality Trusts (CDLHT), and Far East Hospitality Trust (FEHT). Whilst Ascott posted a 95% distribution per unit growth in the first half, Far East and CDL lagged behind with a 7% growth and 19% contraction, respectively.\nIt noted that demand for hotels was still primarily supported by the government, as hotels serving as isolation facilities jumped to more than 90 as of 4 August from over 70 in May.\n“Currently, six out of FEHT’s nine hotels, two out of ART’s three Singapore properties, and five out of CDLHT’s six Singapore hotels are on government isolation businesses. REIT Managers see a high likelihood that existing contracts would be extended in [the third quarter of 2021] as the COVID-19 situation remains fluid, and governments may still need some inventory of rooms for imported cases. These could continue to provide income support before an eventual recovery of the hospitality sector as Singapore progressively reopens its borders,” OCBC said.\nIt flagged as a potential downside risk of more COVID-19 infections due to the Delta variant.\nPotential growth drivers include high vaccination rates, the vaccinated travel lanes with Germany and Brunei starting 8 September, and the lifting of border restrictions for visitors from Hong Kong and Brunei.\n“As governments step up immunisation efforts both locally and globally, Singapore is likely to reopen its borders to more destinations in a careful and calibrated manner. Whilst visitor arrivals may remain muted in the near term as vaccination rates and border measures vary in countries, we believe the reopening of borders marks a measured start to the resumption of air travel, aiding the recovery of the hospitality sector, barring the risks of a potential spike in Delta variant cases,” OCBC said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":859695039,"gmtCreate":1634690870572,"gmtModify":1634690870688,"author":{"id":"3586754499068036","authorId":"3586754499068036","name":"Retailer","avatar":"https://static.tigerbbs.com/5ad4e71e4667e8585882bc3b08fd0845","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586754499068036","authorIdStr":"3586754499068036"},"themes":[],"htmlText":"Thank you for sharinf","listText":"Thank you for sharinf","text":"Thank you for sharinf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859695039","repostId":"2175144894","repostType":2,"isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}